Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: Comparison with non-demented cases and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 4, 2000, Pages 187-192

  Armstrong, R A ^a   Cairns, N J ^b   Lantos, P L ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

'Amyloid cascade hypothesis'; Alzheimer's disease; Dementia with Lewy bodies; Non demented patients; Temporal lobe; Amyloid deposition

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; LEWY BODY; PATHOGENESIS; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0034047021     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017235     Document Type: Article

References (37)

1. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock DM, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
2. Kosaka K, Iseki E, Odawara T, Yamamoto T: Cerebral type of Lewy body disease. Neuropathology 1996;16:32-35.
3. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R: Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996;31:148-165.
4. Gibb WRG, Luthert PJ, Janota I, Lantos PL: Cortical Lewy body dementia: Clinical features and classification. J Neurol Neurosurg Psychiatry 1989;52:185-192.
5. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen SH: Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscope immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991;41:1402-1409.
6. Armstrong RA, Cairns NJ, Lantos PL: β-Amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 1997;227:193-196.
7. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
8. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P: The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 1988;38:359-364.
9. Armstrong RA: Differences of β-amyloid (β/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci Lett 1994;169:133-136.
10. Rezaie P, Cairns NJ, Chadwick A, Lantos PL: Lewy bodies are located prefentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 1996;212:111-114.
11. Armstrong RA, Cairns NJ, Lantos PL: Dementia with Lewy bodies: Clustering of Lewy bodies in human patients. Neurosci Lett 1997;224: 41-44.
12. Armstrong RA, Cairns NJ, Lantos PL: Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies. Alzheimer Rep 1998;1:159-163.
13. Spargo E, Luthert PJ, Anderton BH, Bruce M, Smith D, Lantos PL: Antibodies raised against different proteins of A4 protein identify a subset of plaques in Down's syndrome. Neurosci Lett 1990;115:345-350.
14. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ: Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol 1991;81:328-335.
15. Armstrong RA: Relationships between morphological types of plaque in Alzheimer's disease as revealed in silver and immunostained populations. Neurodegeneration 1993;2:259-266.
16. Armstrong RA: β-Amyloid plaques: Stages in life history or independent origin? Dement Geriatr Cogn Disord 1998;9:227-238.
17. Beach TG, McGeer EG: Senile plaques, amyloid β-protein and acetylcholinesterase fibres: Laminar distribution in Alzheimer's disease striate cortex. Acta Neuropathol 1992;83:292-299.
18. Armstrong RA: β-Amyloid (Aβ) deposits and blood vessels: Laminar distribution in the frontal cortex of patients with Alzheimer's disease. Neurosci Res Commun 1996;18:19-28.
19. Crain BJ, Burger PC: The laminar distribution of neuritic plaques in the fascia dentata of patients with Alzheimer's disease. Acta Neuropathol 1988;76:87-93.
20. Armstrong RA: The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders with particular reference to plaque formation in Alzheimer's disease. Neurodegeneration 1993;2:73-80.
21. Armstrong RA: Analysis of spatial patterns in histological sections of brain tissue. J Neurosci Methods 1997;73:141-147.
22. Armstrong RA: β-Amyloid (Aβ) deposition in elderly non-demented patients and patients with Alzheimer's disease. Neurosci Lett 1994; 178:59-62.
23. Armstrong RA: Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995;6:121-125.
24. Lippa CF, Smith TW, Swearer JM: Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88.
25. Kawanishi C, Suzuki K, Odawara T, Iseki E, Onishi H, Miyakawa T, Yamada Y, Kosaka K, Kondo N, Yamamoto T: Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 1996;136:140-142.
26. Armstrong RA: The ratio of diffuse to mature beta/A4 deposits in Alzheimer's disease varies in cases with an without pronounced congophilic angiopathy. Dementia 1993;4:251-255.
27. Wu E, Lipton B, Dickson DW: Amyloid angiopathy in diffuse Lewy body disease. Neurology 1992;42:2131-2135.
28. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci 1985;82:4531-4534.
29. De Lacoste M, White CL III: The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system. Neurobiol Aging 1993;14:1-16.
30. Armstrong RA: The spatial pattern of discrete β-amyloid deposits in Alzheimer's disease reflects synaptic disconnection. Dementia 1996; 7:86-90.
31. Hansen LA, Salmon D, Galasko D, Masliah E, Katzman R, De Teresa R, Thal L, Pay MM, Hofstetler R, Klauber M, Rice V, Butlers N, Alford M: The Lewy body variant of Alzheimer's disease: A clinical and pathological entity. Neurology 1990;40:1-8.
32. Raghavan R, Khin-Nu C, Brown A, Irving D, Ince PG, Day K, Tyrer SP, Perry RH: Detection of Lewy bodies in trisomy 21 (Down's syndrome). Can J Neurol Sci 1993;20:48-51.
33. Lantos PL, Luthert PJ, Hanger D, Anderton B, Mullan M, Rossor M: Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett 1992;137:221-224.
34. Van Gool D, Destroper B, Vanleuven F, Dom R: Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease. Dementia 1995;6:63-68.
35. Hardy JA, Higgins GA: Alzheimer's disease: The amyloid cascade hypothesis. Science 1992; 256:184-185.
36. Harrington CR, Perry RH, Perry EK, Hurt J, McKeith JG, Roth M, Wischik CM: Senile dementia of the Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau proteins. Dementia 1994;5:215-228.
37. Kazec AM, Han LY: Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 1995;119:448-453.